Long-term follow-up of children and young adults treated with implantable cardioverter-defibrillator: The authors' own experience with optimal implantable cardioverter-defibrillator programming

Europace

Volumn 12, Issue 9, 2010, Pages 1245-1250

  Lewandowski, Michał ^a   Sterliński, MacIej ^a   MacIg, Aleksander ^a   Syska, Paweł ^a   Kowalik, Ilona ^a   Szwed, Hanna ^a   Chojnowska, Lidia ^a   Przybylski, Andrzej ^a  

^a INSTITUTE OF CARDIOLOGY   (Poland)

Author keywords

Antitachycardia pacing effectiveness; Complications; Implantable cardioverter defibrillator; Long term follow up

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BRUGADA SYNDROME; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CHILD; CONGESTIVE CARDIOMYOPATHY; DEATH; DEFIBRILLATOR; DEVICE; EBSTEIN ANOMALY; FALLOT TETRALOGY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART PACING; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HOSPITAL DISCHARGE; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; LONG QT SYNDROME; MAJOR CLINICAL STUDY; MALE; MENTAL STRESS; POSTOPERATIVE COMPLICATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SINUS TACHYCARDIA; T WAVE;

ADOLESCENT; ADULT; CARDIAC PACING, ARTIFICIAL; CHILD; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; SOFTWARE; STROKE VOLUME; TACHYCARDIA; TREATMENT FAILURE; VENTRICULAR FIBRILLATION; YOUNG ADULT;

EID: 77956524605     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euq263     Document Type: Article

References (26)

1. Silka MJ, Kron J, Dunnigan A, Dick M II. Sudden cardiac death and the use of implantable cardioverter-defibrillators in pediatric patients. Circulation 1993;87: 800-807
2. Shannon KM. Use of implantable cardioverter-defibrillators in pediatric patients. Curr Opin Cardiol 2002;17:280-282
3. Fischbach P, Law IH, Dick M II, Leroy S, Mosca R, Serwer GA. Use of single coil transvenous electrode with abdominally placed implantable cardioverterdefibrillator in children. Pace 2000;23:884.
4. Stefanelli CB, Bradley DJ, Leroy S, Dick M II, Serwer GA, Fischbach PS. Implantable cardioverter-defibrillators. Therapy for life-threatening arrhythmias in young patients. J Interv Card Electrophysiol 2002;6:235-244
5. Gradaus R, Hammel D, Kotthoff S, Bocker D. Nonthoracotomy implantable cardioverter-defibrillator in children: use of subcutaneous array leads and abdominally placed implantable cardioverter-defibrillator in children. J Cardiovasc Electrophysiol 2001;12:356-360
6. Hazekamp MG, Blom NA, Schoof PH, Schalij MJ, Dion R. Implantation of cardioverter device in young children: The perirenal approach. Ann Thorac Surg 2001;71: 1382-1383
7. Stephenson E, Batra A, Anjan S, Knilans T, Gow R, Gradaus R et al. A multicentre experience with novel implantable cardioverter defibrillator configuration in the pediatric and congenital heart disease population. J Cardiovasc Electroph 2006; 17:41-46
8. Lewandowski M, Przybylski A, Sterliński M, Macia?g A, Pytkowski M, Jankowska A et al. Implantable cardioverter-defibrillator in children and young adults. Implantation technique, follow-up, complications, holter analysis of the rhythm-single centre experience. Folia Cardiologica 2005;12:842-851
9. Wó jcicka M, Lewandowski M, Smolis-Ba?k E, Szwed H. Psychological and clinical problems in young adults with implantable cardioverter- defibrillators. Polish Heart J 2008;66:1050-1060
10. Gasparini M, Manitica M, Galimberti P, Coltorti F, Ceriotti C, Priori SG. Inferior vena cava loop of the implantable cardioverter-defibrillator endocardial lead: a possible solution of the growth problem in pediatric implantation. Pacing Clin Electrophysiol 2001;24:1706-1708
11. Connolly SJ, Kerr CR, Gent M, Roberts RS, Yusuf S, Gillis AM et al. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. N Engl J Med 2000;342:1385-1391
12. Link MS, Hill SL, Cliff DL. Comparison of frequency of complications of implantable cardioverter-defibrillators in children versus adults. Am J Cardiol 1999;83:263-266
13. Gepner K, Przybylski A, Macia?g A, Sterliński M, Lewandowski M, Syska P et al. Causes of redo procedures in patients with an implantable cardioverter-defibrillator- long term follow-up results. Kardiol Pol 2007;65:893-898
14. Chatrath R, Porter CJ, Ackerman MJ. Role of transvenous implantable cardioverter-defibrillators in preventing sudden cardiac death in children, adolescents, and young adults. Mayo Clin Proc 2002;77:226-231
15. Boriani G, Maron B, Shen W, Spirito P. Prevention of sudden death in hypertrophic cardiomyopathy. Circulation 2004;110:e438-e442.
16. Wilkoff BL, Cook JR, Epstein AE, Greene HL, Hallstrom AP, Hsia H et al. Dual Chamber and VVI implantable defibrillator trial investigators. Dual chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable defibrillator (DAVID) trial. J Am Med Assoc 2002;288:315-323
17. Maron BJ, Spirito P, Shen WK, Haas TS, Formisano F, Link MS et al. Outcomes of patients with implantable cardioverter-defibrillators for prevention of sudden cardiac death in hypertrophic cardiomyopathy. J Am Med Assoc 2007;298: 405-412
18. Lin G, Nishimura RA, Gersh BJ, Phil D, Ommen SR, Ackerman MJ et al. Device complications and inappropriate implantable cardioverter-defibrillator shocks in patients with hypertrophic cardiomyopathy. Heart 2009;95:709-714
19. Etheridge SP. Inappropriate defibrillator therapy in young patients: are dualchamber devices and complex algorithms necessary? J Cardiovasc Electrophysiol 2001;12:1102-1103
20. Love B, Barrett K, Alexander ME, Bevilacqua LM, Epstein MR, Triedman JK et al. Supraventricular arrhythmias in children and young adults with implantable cardioverter-defibrillators. J Cardiovasc Electrophysiol 2001;12:1097-1101
21. Sola CL, Bostwick JM. Implantable cardioverter-defibrillators, induced anxiety, and quality of life. Mayo Clin Proc 2005;80:232-237
22. Almquist A, Montgomery J, Haas T, Maron B. Cardioverter-defibrillator implantation in high-risk patients with hypertrophic cardiomyopathy. Heart Rhythm 2005;2:814-819
23. Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkisson WO et al. Prospective randomized multiceneter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillator. Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (Pain Free Rx II) trial results. Circulation 2004;110: 2591-2596
24. Wilkoff BL, Ousdigian KT, Sterns LD, Wang ZJ, Wilson RD, Morgan JMA. Comparison of empiric to physician tailored programming of implantable cardioverterdefibrillator. Results from the prospective randomized multicenter EMPIRIC trial. JACC 2006;48:330-339
25. Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW et al. Strategic programming of detection and therapy parameters in implantable cardioverterdefibrillators reduces shocks in primary prevention patients. Results from the PREPARE (Primary Prevention Parameters Evaluation) study. JACC 2008;52: 541-550
26. Syska P, Przybylski A, Chojnowska L, Lewandowski M, Sterliński M, Macia?g A et al. Implantable cardioverter-defibrillator in patients with hypertrophic cardiomyopathy: efficacy and complications of the therapy in long-term follow-up. J Cardiovas Electrophysiol 2010; Published online ahead of print 1 February 2010, doi:10.1111/j.1540-8167.2009.01716.x